SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Legence Corp. Class A Common stock (LGN) has a negative trailing P/E of -59.5, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 72.6 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -1.68%, forward earnings yield 1.38%. PEG 2.05.
Criteria proven by this page:
- VALUE (50/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
- Forward P/E 72.6 — analysts expect a return to profitability with estimated EPS of $0.91 for FY2026.
- PEG Ratio 2.05 — above 2.0 suggests expensive relative to earnings growth.
- Trailing Earnings Yield -1.68% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 1.38% as earnings recover.
- Analyst consensus target $52.60 (-20.4% downside) — analysts see meaningful downside risk at the current price level.
Overall SharesGrow Score: 39/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
~
VALUE
50/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — LGN
Valuation Multiples
P/E (TTM)-59.5
Forward P/E72.6
PEG Ratio2.05
Forward PEG2.05
P/B Ratio9.06
P/S Ratio2.50
EV/EBITDA36.2
Per Share Data
EPS (TTM)$-1.00
Forward EPS (Est.)$0.91
Book Value / Share$13.24
Revenue / Share$42.82
FCF / Share$3.68
Yields & Fair Value
Earnings Yield-1.68%
Forward Earnings Yield1.38%
Dividend Yield0.00%
SharesGrow IV$674.44 (+921%)
Analyst Target$52.60 (-20.4%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2022 |
-21.7 |
0.00 |
0.00 |
1.43 |
0.02% |
| 2023 |
-38.8 |
0.87 |
0.00 |
1.10 |
0.09% |
| 2024 |
183.6 |
-1.51 |
0.00 |
0.85 |
16.90% |
| 2025 |
-42.8 |
0.04 |
6.52 |
1.00 |
- |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2022 |
$-0.81 |
$1.25B |
$-82.27M |
-6.6% |
| 2023 |
$-0.45 |
$1.62B |
$-46.03M |
-2.8% |
| 2024 |
$0.10 |
$2.1B |
$9.72M |
0.5% |
| 2025 |
$-1.01 |
$2.55B |
$-59.78M |
-2.3% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$0.81 |
$0.64 – $1.11 |
$3.69B |
$3.56B – $3.7B |
8 |
| 2027 |
$1.05 |
$0.87 – $1.19 |
$4.17B |
$4.03B – $4.31B |
7 |
| 2028 |
$1.60 |
$1.53 – $1.67 |
$4.64B |
$4.48B – $4.8B |
1 |
| 2029 |
$2.34 |
$2.24 – $2.44 |
$5.16B |
$4.98B – $5.34B |
1 |
| 2030 |
$3.06 |
$2.92 – $3.20 |
$5.84B |
$5.64B – $6.04B |
1 |
